MRG15 alternative splicing regulates CDK1 transcriptional activity in mouse cell senescence and myocardial

Yuan Zhang1,2,3, Huayu Wang1, Fang Li1

  • 1Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

PubMed

Insights

The splice variant MRG15L accumulates with age, promoting cellular senescence and impairing cardiac repair. Targeting MRG15L may offer new therapies for age-related diseases and enhance heart regeneration.

Area of Science:

  • Molecular Biology
  • Gerontology
  • Cardiovascular Research

Background:

  • The chromatin remodeling protein MRG15 is implicated in cellular senescence and proliferation.
  • The specific roles and mechanisms of MRG15 in aging regulation are not fully understood.
  • Alternative splicing generates different MRG15 variants with potentially distinct functions.

Purpose of the Study:

  • To elucidate the distinct functions of MRG15 splice variants in aging.
  • To investigate the role of MRG15L in cellular senescence and cardiac aging.
  • To assess MRG15L as a potential therapeutic target for age-related cardiovascular conditions.

Main Methods:

  • Histone peptide binding assays to assess protein-histone interactions.
  • Protein interaction analysis to identify binding partners.
  • In vivo studies using mouse models of cardiac injury and aging.

Main Results:

  • MRG15L, not MRG15S, accumulates with age.
  • MRG15L shows reduced binding to acetylated histone H4, weakening CDK1 regulation and causing G2/M arrest, thus promoting senescence.
  • Increased MRG15L during cardiac development correlates with reduced regenerative capacity.
  • MRG15L knockout in mice improves cardiac repair after ischemia-reperfusion injury.

Conclusions:

  • MRG15L plays a critical role in promoting cellular senescence and impairing cardiac regeneration during aging.
  • Alternative splicing of MRG15 significantly impacts aging pathways.
  • MRG15L is a potential therapeutic target for age-related diseases, particularly for enhancing cardiac repair.

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.1K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K